文献速递类风湿关节炎

类风湿关节炎患者多病共存与感染风险:基于人群的病例对照研究

Multimorbidity and risk of infection in patients with rheumatoid arthritis: Population-based case-control study.
PubMed 文献 · Semin Arthritis Rheum · 2026-03-21

该研究在韩国全国性数据库中纳入2018-2019年确诊的类风湿关节炎(RA)患者,采用巢式病例对照设计,将2020年1月至2022年4月首次发生严重、机会性或带状疱疹感染的患者与按年龄、性别和血清阳性匹配的对照比较。结果显示,与慢性病少于10种者相比,合并≥10种慢性病的RA患者感染风险更高,且呈剂量反应模式, adjusted OR 分别为严重感染1.44(95%CI 1.32-1.58)、机会性感染2.19(1.06-4.53)和带状疱疹1.18(1.05-1.34),非致命性感染风险增加而致命性感染无显著增加。

要点

  • RA患者多病共存数量与感染风险呈剂量反应关系,≥10种慢性病者风险显著升高。
  • 严重感染、机会性感染和带状疱疹的调整OR分别为1.44、2.19和1.18。
  • 多病共存主要增加非致命性感染风险,致命性感染未见显著增加。

核心结论

  • 在韩国RA成人中,多病共存以剂量反应方式显著增加感染风险,尤其对皮肤和非致命性感染。

研究设计与样本

  • 韩国全国性巢式病例对照研究,使用健康保险审查评估数据库映射至OMOP CDM。
  • RA通过ICD-10(M05-M06)及2018-2019年同日改善病情抗风湿药处方识别,排除重大免疫缺陷或近期感染。
  • 病例为2020年1月1日至2022年4月30日首次严重、机会性或带状疱疹感染,每个病例按年龄、性别和血清阳性匹配4名对照。
  • 多病共存通过感染前2年内存在的慢性病评估。

主要发现

  • 与慢性病<10种者相比,合并≥10种慢性病的RA患者感染风险更高,呈剂量反应模式。
  • 调整OR:严重感染1.44(95%CI 1.32-1.58),机会性感染2.19(95%CI 1.06-4.53),带状疱疹1.18(95%CI 1.05-1.34)。
  • 关联在各亚组中一致;多病共存增加非致命性感染风险,但不增加致命性感染风险。
  • 主要感染类型中,仅复杂性皮肤和软组织感染具有显著性。

关键数值与推荐

  • RA定义:ICD-10编码M05-M06且2018-2019年同日有改善病情抗风湿药处方。
  • 多病共存分组比较:≥10种慢性病 vs <10种慢性病。
  • 感染结局包括严重感染、机会性感染和带状疱疹。

临床怎么用

  • 对RA患者应综合管理慢性病负担,并主动监测感染风险,尤其合并不少于10种慢性病者。
  • 多病共存主要与非致命性感染相关,提示需关注皮肤软组织感染等非致命性感染事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with rheumatoid arthritis (RA) have elevated infection risk owing to disease- and treatment-related immune dysfunction. Whether multimorbidity adds risk remains uncertain. This study evaluated the association between multimorbidity and infection in RA. METHODS: A nationwide nested case-control study was conducted in Korea using the Health Insurance Review and Assessment Service database mapped to the Observational Medical Outcomes Partnership Common Data Model. RA was identified by the International Classification of Diseases, 10th revision (M05-M06) with same-day disease-modifying antirheumatic drug prescriptions in 2018-2019. Patients with major immunodeficiencies or recent infections were excluded. Cases were the first serious, opportunistic, or herpes zoster infections between January 1, 2020, and April 30, 2022. Four controls were matched to each case by age, sex, and seropositivity. Multimorbidity was assessed using chronic conditions present during the 2 years preceding infection. RESULTS: Compared with patients with <10 conditions, those with RA and ≥10 conditions had higher odds of infection. A dose-response pattern was evident across multimorbidity groups. Adjusted odds ratios were 1.44 (95% confidence interval 1.32-1.58) for serious infection, 2.19 (1.06-4.53) for opportunistic infection, and 1.18 (1.05-1.34) for herpes zoster. Associations were consistent across subgroups. Multimorbidity increased nonfatal but not fatal infections. Among major infection types, only complicated skin and soft tissue infections were significant. CONCLUSION: In Korean adults with RA, multimorbidity substantially increases infection risk in a dose-response manner, particularly for cutaneous and nonfatal infections. These results highlight the cumulative impact of chronic conditions and support holistic management with proactive infection monitoring.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. You SH, Minn DK, Cha YJ, et al. Multimorbidity and risk of infection in patients with rheumatoid arthritis: Population-based case-control study. Semin Arthritis Rheum. 2026. PMID: 41932225. doi:10.1016/j.semarthrit.2026.152969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。